Vise Technologies, Inc. Abbott Laboratories Transaction History

Vise Technologies, Inc.

$771 Million
Q3 2024

A detailed history of Vise Technologies, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Vise Technologies, Inc. holds 15,648 shares of ABT stock, worth $1.84 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

15,648

Previous 6,147 154.56%

Holding current value

$1.84 Million

Previous $638,000 179.62%

% of portfolio

0.23%

Previous 0.11%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$100.07 - $118.13 $950,765 - $1.12 Million	9,501 Added 154.56%	15,648 $1.78 Million
Q2 2024 Aug 01, 2024	BUY	$100.73 - $112.44 $238,931 - $266,707	2,372 Added 62.83%	6,147 $638,000
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $35,265 - $38,949	-322 Reduced 7.86%	3,775 $429,000
Q4 2023 Feb 07, 2024	SELL	$90.19 - $110.4 $43,381 - $53,102	-481 Reduced 10.51%	4,097 $450,000
Q3 2023 Oct 31, 2023	BUY	$95.53 - $114.62 $130,111 - $156,112	1,362 Added 42.35%	4,578 $443,000
Q2 2023 Aug 08, 2023	BUY	$100.78 - $112.29 $3,728 - $4,154	37 Added 1.16%	3,216 $350,000
Q1 2023 May 10, 2023	BUY	$96.86 - $114.01 $3,971 - $4,674	41 Added 1.31%	3,179 $321,000
Q4 2022 Feb 09, 2023	SELL	$95.06 - $111.52 $28,518 - $33,456	-300 Reduced 8.73%	3,138 $344,000
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $22,254 - $25,766	230 Added 7.17%	3,438 $333,000
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $108,704 - $131,389	1,065 Added 49.7%	3,208 $349,000
Q1 2022 Jun 08, 2022	BUY	$114.02 - $139.04 $244,344 - $297,962	2,143 New	2,143 $254,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vise Technologies, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vise Technologies, Inc. with notifications on news.

Account

Vise Technologies, Inc. Abbott Laboratories Transaction History